Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: Evidence from a case-control study of non-small-cell lung cancer and a meta-analysis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wu, Haijian ^a   Qiao, Naian ^a   Wang, Yang ^a   Jiang, Man ^b   Wang, Shikun ^a   Wang, Cuihong ^a   Hu, Likuan ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CATALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, GENETIC; TELOMERASE; URINARY BLADDER NEOPLASMS;

EID: 84896737631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076372     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61:69-90.
2. Brawley OW (2011) Avoidable cancer deaths globally. CA Cancer J Clin 61:67-68.
3. Ramalingam SS, Owonikoko TK, Khuri FR (2011) Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin 61:91-112.
4. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40:1404-1406.
5. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85:679-691.
6. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40:1407-1409.
7. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638-642. (Pubitemid 351483366)
8. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633-637. (Pubitemid 351483367)
9. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40:616-622. (Pubitemid 351601203)
10. Calado RT, Young NS (2009) Telomere diseases. N Engl J Med 361:2353-2365.
11. Harley CB (2008) Telomerase and cancer therapeutics. Nat Rev Cancer 8:167-179.
12. Martínez P, Blasco MA (2011)Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11:161-176.
13. Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, et al. (2012) Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst 104:840-854.
14. Baird DM (2010) Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med. 12:e16.
15. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41:221-227.
16. Choi JE, Kang HG, Jang JS, Choi YY, Kim MJ, et al. (2009) Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 18:2773-2781.
17. Savage SA, Chanock SJ, Lissowska J, Brinton LA, Richesson D, et al. (2007) Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer 97:832-836. (Pubitemid 47396285)
18. Liu Z, Li G, Wei S, Niu J, Wang LE, et al. (2010) Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 31:1977-1981.
19. Chen H, Chen Y, Zhao Y, Fan W, Zhou K, et al. (2011)Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol 173:915-922.
20. Ding CY, Hu LM, Hu ZB, Shen HB (2011) The relationship between gene polymorphism of telomerase reverse transcriptase and susceptibility to hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 45:593-596.
21. Gago-Dominguez M, Jiang X, Conti DV, Castelao JE, Stern MC, et al. (2011) Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis 32:197-202.
22. Wang S, Wu J, Hu L, Ding C, Kan Y, et al. (2012) Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population. Mol Carcinog 51 Suppl 1:E118-122.
23. Hofer P, Baierl A, Bernhart K, Leeb G, Mach K, et al. (2012) Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk. Mol Carcinog 51 Suppl 1:E176-182.
24. Zhang C, Tian YP, Wang Y, Guo FH, Qin JF, et al. (2013) hTERT rs2736098 genetic variants and susceptibility of hepatocellular carcinoma in the Chinese population: a case-control study. Hepatobiliary Pancreat Dis Int 12:74-79.
25. Li C, Yin Z, Wu W, Li X, Ren Y, et al. (2013) Genetic Variations in TERT-CLPTM1L Genes and Risk of Lung Cancer in Chinese Women Nonsmokers. PLoS One 8:e64988.
26. Sheng X, Tong N, Tao G, Luo D, Wang M, et al. (2013) TERT polymorphisms modify the risk of acute lymphoblastic leukemia in Chinese children. Carcinogenesis 34:228-235.
27. Zhao Z, Li C, Yang L, Zhang X, Zhao X, et al. (2013) Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population. Exp Lung Res 39:91-98.
28. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826. (Pubitemid 27465551)
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
30. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
31. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. (Pubitemid 34746062)
32. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560. (Pubitemid 37088507)
33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
35. Feldser DM, Hackett JA, Greider CW (2003) Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 3:623-627. (Pubitemid 37328834)
36. Günes C, Rudolph KL (2013) The role of telomeres in stem cells and cancer. Cell 152:390-393.
37. Kang JU, Koo SH, Kwon KC, Park JW, Kim JM (2008) Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 182:1-11. (Pubitemid 351323956)
38. Lan Q, Cawthon R, Gao Y, Hu W, Hosgood HD 3rd, et al. (2013) Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS One 8:e59230.
39. Shen M, Cawthon R, Rothman N, Weinstein SJ, Virtamo J, et al. (2011) A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer 73:133-137.
40. Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, et al. (2008) Telomere length and the risk of lung cancer. Cancer Sci 99:1385-1389. (Pubitemid 351761728)
41. Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, et al. (2010) The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet 6. pii: e1001051.
42. Jin G, Xu L, Shu Y, Tian T, Liang J, et al. (2009) Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 30:987-990.
43. Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, et al. (2004) Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer 90:1222-1229. (Pubitemid 38496817)
44. Lantuéjoul S, Salon C, Soria JC, Brambilla E (2007) Telomerase expression in lung preneoplasia and neoplasia. Int J Cancer 120:1835-1841. (Pubitemid 46418357)
45. Zhu CQ, Cutz JC, Liu N, Lau D, Shepherd FA, et al. (2006) Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer 94:1452-1459. (Pubitemid 43772280)